Total Payments
$439,242
2024 Payments
$42,933
Companies
48
Transactions
1,780
Medicare Patients
3,360
Medicare Billing
$248,087
Payment Breakdown by Category
Other$370,658 (84.4%)
Food & Beverage$28,275 (6.4%)
Consulting$22,311 (5.1%)
Travel$17,694 (4.0%)
Education$303.53 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $370,658 | 217 | 84.4% |
| Food and Beverage | $28,275 | 1,388 | 6.4% |
| Consulting Fee | $22,311 | 25 | 5.1% |
| Travel and Lodging | $17,694 | 137 | 4.0% |
| Education | $303.53 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $345,076 | 590 | $0 (2024) |
| Mylan Specialty L.P. | $65,585 | 193 | $0 (2024) |
| GlaxoSmithKline, LLC. | $17,958 | 275 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,052 | 131 | $0 (2024) |
| United Therapeutics Corporation | $689.12 | 39 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $615.12 | 58 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $600.72 | 41 | $0 (2024) |
| Genentech USA, Inc. | $598.26 | 75 | $0 (2019) |
| Grifols USA, LLC | $520.27 | 27 | $0 (2024) |
| Insmed, Inc. | $487.99 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42,933 | 160 | AstraZeneca Pharmaceuticals LP ($37,660) |
| 2023 | $39,670 | 185 | AstraZeneca Pharmaceuticals LP ($33,933) |
| 2022 | $40,988 | 201 | AstraZeneca Pharmaceuticals LP ($25,951) |
| 2021 | $145,408 | 252 | AstraZeneca Pharmaceuticals LP ($132,608) |
| 2020 | $54,263 | 175 | AstraZeneca Pharmaceuticals LP ($29,306) |
| 2019 | $35,644 | 305 | Mylan Specialty L.P. ($23,289) |
| 2018 | $22,266 | 247 | AstraZeneca Pharmaceuticals LP ($19,764) |
| 2017 | $58,069 | 255 | AstraZeneca Pharmaceuticals LP ($56,283) |
All Payment Transactions
1,780 individual payment records from CMS Open Payments — Page 1 of 72
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $934.50 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Pulmonology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $17.04 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | INOGEN, INC. | INOGEN AT HOME STATIONARY CONCENTRATOR (Device) | Food and Beverage | Cash or cash equivalent | $8.62 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Breas Medical, Inc. | Vivo 45 LS (Device) | Food and Beverage | In-kind items and services | $61.47 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Airway Clearance Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 609 | 711 | $155,625 | $47,432 |
| 2022 | 20 | 688 | 794 | $179,910 | $53,480 |
| 2021 | 24 | 910 | 1,095 | $233,274 | $71,338 |
| 2020 | 22 | 1,153 | 1,431 | $260,685 | $75,836 |
Total Patients
3,360
Total Services
4,031
Medicare Billing
$248,087
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 191 | $49,660 | $16,127 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 128 | $22,400 | $7,881 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $26,465 | $7,365 | 27.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 21 | $14,175 | $3,403 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 23 | $8,050 | $3,003 | 37.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $7,425 | $2,466 | 33.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $6,500 | $2,012 | 31.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,815 | $828.35 | 45.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 40 | 47 | $3,175 | $712.81 | 22.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 18 | 18 | $2,790 | $712.13 | 25.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 17 | 17 | $2,805 | $644.00 | 23.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 18 | 18 | $3,150 | $487.05 | 15.5% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 11 | 11 | $1,188 | $423.17 | 35.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $767.00 | $379.21 | 49.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 16 | 31 | $1,116 | $245.22 | 22.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 12 | 13 | $455.00 | $182.00 | 40.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 23 | 23 | $667.00 | $175.03 | 26.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 16 | $2,069 | $148.68 | 7.2% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 11 | 11 | $605.00 | $137.61 | 22.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 12 | 12 | $348.00 | $99.48 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 163 | $42,380 | $13,822 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 162 | $28,350 | $9,522 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 77 | 77 | $30,415 | $8,197 | 26.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 21 | 38 | $25,650 | $6,278 | 24.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $9,900 | $3,138 | 31.7% |
About Dr. Michael Wert, M.D
Dr. Michael Wert, M.D is a Internal Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558310276.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Wert, M.D has received a total of $439,242 in payments from pharmaceutical and medical device companies, with $42,933 received in 2024. These payments were reported across 1,780 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($370,658).
As a Medicare-enrolled provider, Wert has provided services to 3,360 Medicare beneficiaries, totaling 4,031 services with total Medicare billing of $248,087. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Greensboro, NC
- Active Since 05/09/2006
- Last Updated 12/05/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558310276
Products in Payments
- BREZTRI (Drug) $210,597
- Yupelri (Drug) $53,030
- BEVESPI AEROSPHERE (Drug) $49,070
- SYMBICORT (Drug) $33,086
- BREZTRI AEROSPHERE (Drug) $29,060
- AIRSUPRA (Drug) $18,493
- TRELEGY ELLIPTA (Drug) $15,879
- YUPELRI (Drug) $12,533
- DALIRESP (Drug) $3,555
- OFEV (Drug) $1,288
- NUCALA (Biological) $1,045
- DUPIXENT (Biological) $658.19
- Arikayce (Drug) $487.99
- TYVASO (Drug) $478.19
- XOLAIR (Biological) $455.71
- GLASSIA (Biological) $443.93
- Xolair (Biological) $430.44
- TEZSPIRE (Biological) $414.25
- FASENRA (Biological) $382.79
- ANORO (Drug) $376.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greensboro
Dr. Daniel Bensimhon, Md, MD
Internal Medicine — Payments: $2.3M
Internal Medicine $2.3M
Mark Russo, Md, MD
Internal Medicine — Payments: $318,372
Internal Medicine $318,372
Julian Hutchins, Md, MD
Internal Medicine — Payments: $222,266
Internal Medicine $222,266
Dr. James Beekman, Md, MD
Internal Medicine — Payments: $116,445
Internal Medicine $116,445
Walter Pharr, M.d, M.D
Internal Medicine — Payments: $53,823
Internal Medicine $53,823
Murali Ramaswamy, Md Faafp, MD FAAFP
Internal Medicine — Payments: $45,364
Internal Medicine $45,364